Drug combo eradicated Breast Cancer tumors in 11 days

A cancer drug duo could one day eliminate the need for chemotherapy for women with HER2-positive breast cancer; in a new study, a combination of two drugs was found to completely eradicate or significantly shrink breast cancer tumors within 11 days of diagnosis. Lead researcher Prof. Judith Bliss, of the Institute of Cancer Research (ICR) in the UK, and colleagues recently presented the results of their EPHOS B Trial at 10th European Breast Cancer Conference (EBCC-10) in Amsterdam, the Netherlands. Based on their findings, the researchers suggest that therapy involving a combination of trastuzumab and lapatinib prior to surgery could be an effective treatment option for women with HER2-positive breast cancer, potentially eliminating the need for chemotherapy.